|
WC
|
Sens. %
|
Spec.%
|
PPV %
|
NPV %
|
Youden
|
Prevalence MetSc (%)
|
Odds ratiod
|
|---|
|
Value
|
95% CI
|
|---|
|
Men
|
|
90a
|
77.9
|
53.3
|
74.9
|
57.4
|
0.3119
|
54.1
|
1.26
|
1.22–1.30
|
|
91
|
74.8
|
57.6
|
76.0
|
56.0
|
0.3241
|
52.9
|
1.38
|
1.32–1.44
|
|
92
|
71.2
|
61.2
|
76.7
|
54.3
|
0.3245
|
51.5
|
1.50
|
1.42–1.59
|
|
93
|
67.7
|
64.5
|
77.4
|
52.7
|
0.3220
|
50.1
|
1.64
|
1.53–1.76
|
|
94b
|
63.9
|
67.2
|
77.7
|
50.9
|
0.3110
|
48.6
|
1.78
|
1.64–1.93
|
|
95
|
59.7
|
70.8
|
78.5
|
49.5
|
0.3048
|
47.0
|
1.93
|
1.76–2.12
|
|
96
|
56.0
|
73.6
|
79.1
|
48.3
|
0.2954
|
45.7
|
2.09
|
1.88–2.32
|
|
97
|
52.2
|
76.6
|
80.0
|
47.2
|
0.2884
|
44.3
|
2.25
|
2.01–2.52
|
|
98
|
48.4
|
80.0
|
81.2
|
46.4
|
0.2836
|
43.0
|
2.42
|
2.14–2.73
|
|
99
|
44.8
|
82.8
|
82.3
|
45.5
|
0.2755
|
41.8
|
2.59
|
2.27–2.94
|
|
100
|
40.9
|
85.0
|
83.0
|
44.5
|
0.2593
|
40.4
|
2.76
|
2.41–3.15
|
|
101
|
37.9
|
86.5
|
83.4
|
43.8
|
0.2444
|
39.6
|
2.93
|
2.56–3.35
|
|
102
|
34.3
|
88.1
|
83.8
|
42.8
|
0.2244
|
38.4
|
3.10
|
2.71–3.55
|
|
Women
|
|
80ab
|
87.4
|
41.9
|
55.3
|
80.2
|
0.2932
|
40.5
|
1.11
|
1.09–1.12
|
|
81
|
84.8
|
46.4
|
56.5
|
78.8
|
0.3122
|
39.8
|
1.22
|
1.19–1.25
|
|
82
|
82.4
|
50.3
|
57.6
|
77.6
|
0.3265
|
39.0
|
1.34
|
1.30–1.39
|
|
83
|
79.4
|
53.9
|
58.6
|
76.0
|
0.3322
|
38.1
|
1.48
|
1.42–1.54
|
|
84
|
77.2
|
57.6
|
59.9
|
75.5
|
0.3478
|
37.6
|
1.62
|
1.55–1.70
|
|
85
|
74.3
|
61.4
|
61.3
|
74.4
|
0.3574
|
36.6
|
1.77
|
1.68–1.87
|
|
86
|
70.8
|
65.1
|
62.5
|
73.0
|
0.3589
|
35.6
|
1.93
|
1.83–2.05
|
|
87
|
67.5
|
68.2
|
63.5
|
71.8
|
0.3566
|
34.7
|
2.10
|
1.98–2.24
|
|
88
|
64.1
|
71.1
|
64.5
|
70.6
|
0.3513
|
33.7
|
2.28
|
2.14–2.44
|
|
89
|
60.5
|
73.6
|
65.4
|
69.4
|
0.3419
|
32.6
|
2.47
|
2.30–2.66
|
|
90
|
57.1
|
76.2
|
66.4
|
68.4
|
0.3333
|
31.6
|
2.67
|
2.47–2.89
|
- Brazilian Longitudinal Study of Adult Health (ELSA-Brasil), 2008–2010
- WC waist circumference, Sens. sensitivity, Spec. specificity, PPV positive predictive value, NPV negative predictive value, MetS metabolic syndrome, 95% CI 95% confidence interval
- a Cut-off suggested by the Joint Interim Statement (JIS) for Central and South Americans ethnic groups
- b Cut-off suggested by the JIS for white Caucasians/Europids or black Sub-Saharan African origin
- c Prevalence in the overall sex-specific sample
- d Relative odds of the metabolic syndrome being present above the cut-off point, reference strata being the lowest 25% of WCs
